Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Quan, Dianna
COURAGE OLE, NCT05442775 / 2021-004727-33: A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)	Terminated	3	71	Europe, Canada, US, RoW	Reldesemtiv	Cytokinetics, Cytokinetics Inc	Amyotrophic Lateral Sclerosis	06/23	06/23
Haakonsen, Nicola
NCT06705478: Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV	Not yet recruiting	2	186	US, RoW	Pramipexole ER, Escitalopram	National Institute of Allergy and Infectious Diseases (NIAID), Cipla Ltd.	Major Depressive Disorder, Mild Neurocognitive Disorder, HIV	12/26	12/26
BACI, NCT04064710: Biological Allograft Chain Tissue Implant	Recruiting	N/A	26	US	Vertebral Body Augmentation, Manual Surgical Instruments	Lenoss Medical, MCRA, LLC	Vertebral Body Compression Fracture(s)	08/22	12/22